DZ Bank Aktienanleihe SNW 27.09.2.../ DE000DJ6XHB7 /
5/17/2024 9:06:00 AM | Chg.-0.10 | Bid9:46:18 PM | Ask9:46:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
99.93EUR | -0.10% | 99.46 Bid Size: 50,000 |
99.86 Ask Size: 50,000 |
SANOFI SA INHABER ... | 85.00 - | 9/27/2024 | Call |
GlobeNewswire
9:00 PM
Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and ...
GlobeNewswire
5/13
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire
5/13
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
5/13
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
5/10
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire
5/8
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
5/7
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
5/2
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
4/25
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire
4/23
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire
4/17
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...